Cellular mechanisms of fatal early-onset autoimmunity in mice with the T cell-specific targeting of transforming growth factor-β receptor

被引:411
作者
Marie, Julien C.
Liggitt, Denny
Rudensky, Alexander Y. [1 ]
机构
[1] Univ Washington, Sch Med, Howard Hughes Med Inst, Seattle, WA 98195 USA
[2] Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA
[3] Univ Washington, Sch Med, Dept Comparat Med, Seattle, WA 98195 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1016/j.immuni.2006.07.012
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Transforming growth factor-beta (TGF-beta) has been implicated in the control of differentiation and proliferation of multiple cell types. However, a role for TGF-beta in the control of immune homeostasis is not fully understood because of its pleiotropic action. Here we report that complete ablation of the TGF-beta signaling in T cells engendered aggressive early-onset, multiorgan, autoimmune-associated lesions with 100% mortality. Peripheral CD4(+) and CD8(+) T cells with TGF-beta-receptor II (TGF-beta RII) deficiency activated cytolytic and T helper 1 (Th1) differentiation program in a cell-intrinsic T cell receptor (TCR)-specific fashion. Furthermore, TGF-beta RII deficiency blocked the development of canonical CD1d-restricted NKT cells. Instead, it facilitated generation of a highly pathogenic T cell subset exhibiting multiple hallmarks of NK cells and sharply elevated amounts of FasL, perforin, granzymes, and interferon-gamma. Thus, TGF-beta signaling in peripheral T cells is crucial in restraining TCR activation-dependent Th1, cytotoxic, and NK cell-like differentiation program which, when left unchecked, leads to rapidly progressing fatal autoimmunity.
引用
收藏
页码:441 / 454
页数:14
相关论文
共 43 条
[1]   T-bet binding to newly identified target gene promoters is cell type-independent but results in variable context-dependent functional effects [J].
Beima, KM ;
Miazgowicz, MM ;
Lewis, MD ;
Yan, PS ;
Huang, THM ;
Weinmann, AS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (17) :11992-12000
[2]   Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-β signals in vivoi [J].
Chen, ML ;
Pittet, MJ ;
Gorelik, L ;
Flavell, RA ;
Weissleder, R ;
von Boehmer, H ;
Khazaie, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (02) :419-424
[3]   Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-β induction of transcription factor Foxp3 [J].
Chen, WJ ;
Jin, WW ;
Hardegen, N ;
Lei, KJ ;
Li, L ;
Marinos, N ;
McGrady, G ;
Wahl, SM .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (12) :1875-1886
[4]   Induction of foxP3+ regulatory T cells in the periphery of T cell receptor transgenic mice tolerized to transplants [J].
Cobbold, SP ;
Castejon, R ;
Adams, E ;
Zelenika, D ;
Graca, L ;
Humm, S ;
Waldmann, H .
JOURNAL OF IMMUNOLOGY, 2004, 172 (10) :6003-6010
[5]   Requirement for V(alpha)14 NKT cells in IL-12-mediated rejection of tumors [J].
Cui, JQ ;
Shin, T ;
Kawano, T ;
Sato, H ;
Kondo, E ;
Toura, I ;
Kaneko, Y ;
Koseki, H ;
Kanno, M ;
Taniguchi, M .
SCIENCE, 1997, 278 (5343) :1623-1626
[6]   Smad-dependent and Smad-independent pathways in TGF-β family signalling [J].
Derynck, R ;
Zhang, YE .
NATURE, 2003, 425 (6958) :577-584
[7]   T cells that cannot respond to TGF-β escape control by CD4+CD25+ regulatory T cells [J].
Fahlén, L ;
Read, S ;
Gorelik, L ;
Hurst, SD ;
Coffman, RL ;
Flavell, RA ;
Powrie, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 201 (05) :737-746
[8]   Cutting edge:: TGF-β induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7 [J].
Fantini, MC ;
Becker, C ;
Monteleone, G ;
Pallone, F ;
Galle, PR ;
Neurath, MF .
JOURNAL OF IMMUNOLOGY, 2004, 172 (09) :5149-5153
[9]   Regulatory T cell lineage specification by the forkhead transcription factor FoxP3 [J].
Fontenot, JD ;
Rasmussen, JP ;
Williams, LM ;
Dooley, JL ;
Farr, AG ;
Rudensky, AY .
IMMUNITY, 2005, 22 (03) :329-341
[10]   Abrogation of TGFβ signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease [J].
Gorelik, L ;
Flavell, RA .
IMMUNITY, 2000, 12 (02) :171-181